GPLBOTC

Green Planet Bio Engineering Co. Ltd.

Financial Services·Financial Services·Aventura, FL, United States

Green Planet Bio Engineering Co. Ltd. (GPLB): 25 pipeline candidates. Updated within the last hour.

10.0/10

BioSniper Score

2-factor signal · derived from public data

Cash RunwayN/A

N/A

Financial Health10.0

0% dilution

Pipeline MaturityN/A

N/A

Pipeline Breadth10.0

25 candidates

Catalyst MomentumN/A

N/A

Insider SignalN/A

N/A

A transparent, data-derived signal for Green Planet Bio Engineering Co. Ltd.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.

Key Financials

Market Cap

$260K

Cash

$0

Quarterly Burn

$17K

Runway

—

Revenue

—

Pipeline (25 candidates)

DrugPhase
aegis condoms—
conductive silicone electrode (model: foot pad electrode—
denracle dental abutment—
dream bond—
dream cleanse s scaler—
exam gloves mfg. glorious wealth co—
fasttrach single-pass tracheal/esophageal airway system—
green or reprocessed aquamantys bipolar sealer—
greencross surgical mask—
ic-flow™ imaging system 2.0—

Showing 10 of 25 candidates. Sign up for full pipeline.

·CEO: Mr. Jordan Weingarten

Frequently asked questions

How many drug candidates are in Green Planet Bio Engineering Co. Ltd.'s pipeline?

Green Planet Bio Engineering Co. Ltd. (GPLB) has 25 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.

What is Green Planet Bio Engineering Co. Ltd.'s market capitalization?

Green Planet Bio Engineering Co. Ltd.'s market capitalization is approximately $260K.

Who is the CEO of Green Planet Bio Engineering Co. Ltd.?

Mr. Jordan Weingarten is the chief executive officer of Green Planet Bio Engineering Co. Ltd. (GPLB).

Get the full picture on Green Planet Bio Engineering Co. Ltd.

Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.

Start Free AnalysisBrowse Calendar